Comparison Kura Oncology (KURA) with Competitors
Kura Oncology (KURA) industry is Biotechnology.
Operating Margin
KURA-431.50%
Industry-2073.25%
Upside+1641.75%
Debt-to-Equity
KURA9.04%
Industry29.76%
Upside-69.63%
Free Cash Flow Yield
KURA-9.29%
Industry-1.94%
Upside-7.35%
P/E
KURA-3.05
Industry-18.88
Upside+1583.23%
P/S
KURA12.39
Industry9.28
Upside+33.48%
P/B
KURA8.42
Industry4.70
Upside+79.25%